The MATTERHORN Phase III trial has demonstrated that a perioperative regimen combining AstraZeneca’s Imfinzi (durvalumab) with FLOT chemotherap ...

AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been recommended for approval in the European Union (EU) for the treatment of adults with resectable non-small cell lung cancer ...

EMA committee recommends approval of AstraZeneca’s Imfinzi in combo with chemotherapy to treat resectable non-small cell lung cancer ...

Most cases of endometrioid ovarian cancer are diagnosed at an early stage and are low grade. Some women have endometroid ovarian cancer at the same time as a separate womb (endometrial) cancer. Clear ...

Using a mouse model that reflects the TB pathology of granuloma necrosis in humans, the DZIF research team demonstrated the remarkable ability of the new antibiotic BTZ-043 to efficiently ...

Furthermore, in tumor types such as cervical cancer (CESC) and endometrial cancer (UCEC), the epigenetic scores also exhibit a gradual increase with higher tumor grades. This further supports the ...

A study that explored trends in obesity and endometrial cancer in the U.S concluded that the combination of the 2 conditions hits younger women, and Black and Hispanic women in particular ...

Dr Chapman-Davis, welcome to the Medscape InDiscussion: Endometrial Cancer podcast. Eloise Chapman-Davis, MD: Thank you so much, Dr Matulonis. I'm so excited to be able to participate in this ...

Human endometrial cancer cells (HEC-1-B, Wuhan Pricella Biotechnology Co., Ltd., China) were used. These cells were cultured in a specific medium for HEC-1-B cells (GZ10605-500ML, Servicebio, China).

Get Instant Summarized Text (Gist) Long-term consumption of yogurt, specifically two or more servings per week, is associated with a reduced incidence of Bifidobacterium-positive proximal colon cancer ...

Cancer epidemiologists who study diet have long sought to understand the associations between coffee and tea drinking and the risks for a host of cancer types. It’s important to continue ...